Abiopharma

(85% Positive) Phio Pharmaceuticals Corp. (PHIO) Announces Clinical Development Update

(10% Negative) Lipocine Inc. (LPCN) Announces Delay in early Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Hurlburt Elizabeth 🔴 sold 5.8K shares of CorMedix Inc. (CRMD) at $7.15 Transaction Date: Jan 12, 2026 | Filing ID: 005426

Director Todisco Joseph 🟡 adjusted position in 40.1K shares (1 derivative) of CorMedix Inc. (CRMD) at $7.15 Transaction Date: Jan 12, 2026 | Filing ID: 005425

FMR LLC 🔴 sold 4.6M shares (9 derivative) of Structure Therapeutics Inc. (GPCR) Transaction Date: Jan 15, 2026 | Filing ID: 016062

Director Schall Thomas J. 🟢 acquired 21.6K shares of Immuneering Corp (IMRX) at $4.67 Transaction Date: Jan 15, 2026 | Filing ID: 000014

New Form 424B5 - Tharimmune, Inc. Filed: 2026-01-20 AccNo: 0001493152-26-002773 Size: 578 KB

(10% Negative) Interpace Biosciences, Inc. (IDXG) Reports Q1 2026 Financial Results

New Form SC TO-C - RAPT Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-016042 Size: 70 KB

(99% Neutral) Tivic Health Systems Inc. (TIVC) Provides Update on treatments for future operations